Patent Applications published on Dec 30, 2021 - page 4

#901 ✅ Patent 11,426,353 granted on 2022-08-30
US20210401760A1
Human necessities

Composite coating for an active agent

#902 ✅ Patent 11,793,763 granted on 2023-10-24
US20210401761A1
Human necessities

Water-soluble lutein ester microcapsules and a method of preparing the same

#903 ✅ Patent 11,304,911 granted on 2022-04-19
US20210401762A1
Human necessities

Compositions and methods for organ specific delivery of nucleic acids

#904 ✅ Patent 11,564,891 granted on 2023-01-31
US20210401763A1
Human necessities

Chloroquine gel and preparation method and application thereof

#905 ✅ Patent 11,925,712 granted on 2024-03-12
US20210401764A1
Human necessities

Implantable devices for delivery of bioactive agents

#906
US20210401765A1
Human necessities

SPRAY COMPOSITIONS OF CHITOSAN FOR WOUND HEALING

#907
US20210401766A1
Human necessities

Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration

#908 ✅ Patent 11,504,343 granted on 2022-11-22
US20210401767A1
Human necessities

Aqueous adhesive

#909
US20210401768A1
Human necessities

FORMULATIONS OF CANNABINOIDS FOR THE TREATMENT OF DERMATITIS AND INFLAMMATORY SKIN DISEASES

#910
US20210401769A1
Human necessities

TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

#911 ✅ Patent 11,723,880 granted on 2023-08-15
US20210401770A1
Human necessities

Transdermal formulation for the treatment of pain and/or inflammation

#912 ✅ Patent 11,701,330 granted on 2023-07-18
US20210401771A1
Human necessities

Use of cannabinoids in the treatment of epilepsy

#913 ✅ Patent 11,844,767 granted on 2023-12-19
US20210401772A1
Human necessities

Composition and methods for stimulating clearance of amyloid-beta protein

#914
US20210401773A1
Human necessities

ye-COVIDICIN Botanical and Traditional Medicine to Treatment for COVID-19

#915
US20210401774A1
Human necessities

KETAMINE PROTOCOLS AND DATA EVALUATION FOR TREATMENT-RESISTANT DEPRESSION AND TRAUMA

#916
US20210401775A1
Human necessities

A LIQUID INJECTABLE COMPOSITION

#917
US20210401776A1
Human necessities

METHOD OF TREATING REFRACTORY EPILEPSY SYNDROMES USING FENFLURAMINE ENANTIOMERS

#918
US20210401777A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

#919 ✅ Patent 11,400,061 granted on 2022-08-02
US20210401778A1
Human necessities

Onychomycosis treatment compositions and methods

#920
US20210401779A1
Human necessities

PETROLATUM-BASED COMPOSITIONS AND METHODS OF TREATMENT FOR ONYCHOMYCOSIS

#921 ✅ Patent 11,234,947 granted on 2022-02-01
US20210401780A1
Human necessities

Treatment of peripheral neuropathy induced by cancer chemotherapy

#922 ✅ Patent 11,576,878 granted on 2023-02-14
US20210401781A1
Human necessities

Oral solutions comprising lisdexamfetamine salts

#923
US20210401782A1
Human necessities

COMPOSITION FOR PREVENTING AND TREATMENT OF STROKE

#924
US20210401783A1
Human necessities

AGENTS THAT INHIBIT NGLY1 AND METHODS OF USE THEREOF

#925 ✅ Patent 11,793,777 granted on 2023-10-24
US20210401784A1
Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory response

#926 ✅ Patent 11,679,088 granted on 2023-06-20
US20210401785A1
Human necessities

Controlled release dosage form

#927 ✅ Patent 11,737,998 granted on 2023-08-29
US20210401786A1
Human necessities

Composition for treating burn wounds

#928 ✅ Patent 11,813,236 granted on 2023-11-14
US20210401787A1
Human necessities

Substances for treatment of fatty liver-related conditions

#929 ✅ Patent 11,998,520 granted on 2024-06-04
US20210401788A1
Human necessities

Methods for decreasing injuries associated with intraoperative hypotension

#930
US20210401789A1
Human necessities

OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES

#931
US20210401790A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

#932
US20210401791A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING ALCOHOL TOXICITY

#933 ✅ Patent 12,310,940 granted on 2025-05-27
US20210401792A1
Human necessities

Cell-permeable succinate compounds

#934 ✅ Patent 12,233,042 granted on 2025-02-25
US20210401793A1
Human necessities

Treatment of cutaneous disorders

#935
US20210401794A1
Human necessities

Methods of Using Cannabinoid Compositions for Inducing and Promoting Sleep

#936
US20210401795A1
Human necessities

Compressible Cannabinoid Pharmaceutical Composition

#937 ✅ Patent 11,622,957 granted on 2023-04-11
US20210401796A1
Human necessities

Formulations for treating cluster symptoms associated with autism spectrum disorder

#938 ✅ Patent 11,786,504 granted on 2023-10-17
US20210401797A1
Human necessities

Taxane analogs for the treatment of brain cancer

#939
US20210401798A1
Human necessities

LIPOXIN A4 ANALOGS AND USES THEREOF

#940 ✅ Patent 11,890,269 granted on 2024-02-06
US20210401799A1
Human necessities

Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances

#941 ✅ Patent 11,690,823 granted on 2023-07-04
US20210401800A1
Human necessities

Pharmaceutical composition

#942 ✅ Patent 12,144,799 granted on 2024-11-19
US20210401801A1
Human necessities

Method for long-term storage of chlorophyll-containing extract

#943 ✅ Patent 11,844,779 granted on 2023-12-19
US20210401802A1
Human necessities

PKC-Delta-I inhibitor formulations and uses thereof

#944 ✅ Patent 12,285,407 granted on 2025-04-29
US20210401803A1
Human necessities

Bis-indolylmethane derivatives and uses thereof

#945 ✅ Patent 11,389,429 granted on 2022-07-19
US20210401804A1
Human necessities

Use of carbamate compound for preventing, alleviating or treating myotonia

#946
US20210401805A1
Human necessities

Immune CB1 Activation for Obesity Therapy

#947 ✅ Patent 12,109,195 granted on 2024-10-08
US20210401806A1
Human necessities

Compositions and methods for treatment of vaginal infections

#948
US20210401807A1
Human necessities

NEW COMPOSITION COMPRISING AMORPHOUS NANOPOROUS SILICA PARTICLES

#949 ✅ Patent 11,642,332 granted on 2023-05-09
US20210401808A1
Human necessities

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

#950
US20210401809A1
Human necessities

PHARMACEUTICAL COMPOUNDS

#951
US20210401810A1
Human necessities

Helicase Primase Inhibitors For Treating Cancer In A Combination Therapy With Oncolytic Viruses

#952
US20210401811A1
Human necessities

DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST

#953 ✅ Patent 12,220,406 granted on 2025-02-11
US20210401812A1
Human necessities

Compositions for the prevention and treatment of metabolic syndrome

#954 ✅ Patent 11,311,521 granted on 2022-04-26
US20210401813A1
Human necessities

Solid dispersion forms of rifaximin

#955 ✅ Patent 12,178,807 granted on 2024-12-31
US20210401814A1
Human necessities

Macrocyclic tyrosine kinase inhibitor and uses thereof

#956
US20210401815A1
Human necessities

RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA

#957 ✅ Patent 11,890,276 granted on 2024-02-06
US20210401816A1
Human necessities

Methods of treating pancreatic cancer

#958 ✅ Patent 12,201,621 granted on 2025-01-21
US20210401817A1
Human necessities

Base and pharmaceutical composition containing it

#959 ✅ Patent 11,980,612 granted on 2024-05-14
US20210401818A1
Human necessities

Synergistic anti-inflammatory compositions

#960 ✅ Patent 12,133,847 granted on 2024-11-05
US20210401819A1
Human necessities

Pharmaceutical composition and preparation method therefor

#961 ✅ Patent 11,351,160 granted on 2022-06-07
US20210401820A1
Human necessities

Methods of treating cancer

#962
US20210401821A1
Human necessities

PROPHYLACTIC OR THERAPEUTIC AGENT AND MEDICINAL COMPOSITION FOR IL-31-MEDIATED DISEASE

#963 ✅ Patent 12,257,246 granted on 2025-03-25
US20210401822A1
Human necessities

Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl[-benzamide

#964
US20210401823A1
Human necessities

INHIBITORS AND ANTAGONISTS OF GPR84 FOR THE TREATMENT OF ENDOMETRIOSIS

#965
US20210401824A1
Human necessities

Parenteral Formulations of Dopamine Agonists

#966 ✅ Patent 11,883,392 granted on 2024-01-30
US20210401825A1
Human necessities

Pharmaceutical composition for nasal delivery

#967
US20210401826A1
Human necessities

ABUSE DETERRENT PHARMACEUTICAL FORMULATIONS

#968
US20210401827A1
Human necessities

METHODS, PARENTERAL PHARMACEUTICAL FORMULATIONS, AND DEVICES FOR THE PREVENTION OF OPIOID OVERDOSE

#969 ✅ Patent 11,364,233 granted on 2022-06-21
US20210401828A1
Human necessities

Bupropion as a modulator of drug activity

#970 ✅ Patent 11,576,909 granted on 2023-02-14
US20210401829A1
Human necessities

Bupropion as a modulator of drug activity

#971 ✅ Patent 11,617,747 granted on 2023-04-04
US20210401830A1
Human necessities

Bupropion as a modulator of drug activity

#972 ✅ Patent 11,590,124 granted on 2023-02-28
US20210401831A1
Human necessities

Bupropion as a modulator of drug activity

#973 ✅ Patent 11,986,473 granted on 2024-05-21
US20210401832A1
Human necessities

Prevention and/or treatment of contrast-induced acute kidney injury

#974
US20210401833A1
Human necessities

MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE

#975
US20210401834A1
Human necessities

MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE

#976 ✅ Patent 11,771,696 granted on 2023-10-03
US20210401835A1
Human necessities

Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor

#977 ✅ Patent 11,779,583 granted on 2023-10-10
US20210401836A1
Human necessities

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#978
US20210401837A1
Human necessities

TREATMENT OF CANCER

#979
US20210401838A1
Human necessities

IDENTIFICATION OF AGENTS DISPLAYING FUNCTIONAL ACTIVATION OF DOPAMINE D2 AND D4 RECEPTORS

#980
US20210401839A1
Human necessities

EXTRUDATES COMPRISING VITAMIN B9

#981
US20210401840A1
Human necessities

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

#982 ✅ Patent 11,793,812 granted on 2023-10-24
US20210401841A1
Human necessities

Methods of treating endometriosis

#983
US20210401842A1
Human necessities

[6R]-MTHF - an efficient folate alternative in 5-fluorouracil based chemotherapy

#984 ✅ Patent 11,654,146 granted on 2023-05-23
US20210401843A1
Human necessities

Methods for killing antibiotic tolerant bacteria

#985 ✅ Patent 11,701,360 granted on 2023-07-18
US20210401844A1
Human necessities

Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition

#986 ✅ Patent 12,251,383 granted on 2025-03-18
US20210401845A1
Human necessities

Methods and compositions for KRAS inhibitors

#987
US20210401846A1
Human necessities

MEDICAMENT, COMPOUND, COMPOSITION AND METHOD FOR TREATING HERPES

#988 ✅ Patent 11,975,007 granted on 2024-05-07
US20210401847A1
Human necessities

Medicaments containing riboflavin exhibiting improved flowability

#989 ✅ Patent 12,097,205 granted on 2024-09-24
US20210401848A1
Human necessities

Aqueous composition, in particular for treating mucosa and/or wounds

#990 ✅ Patent 12,233,070 granted on 2025-02-25
US20210401849A1
Human necessities

Methods for treating benzodiazepine misuse/use disorder

#991
US20210401850A1
Human necessities

ANTIVIRAL THERAPY

#992
US20210401851A1
Human necessities

PAR-4 AGONISTS FOR THE TREATMENT OF CANCER

#993 ✅ Patent 12,186,325 granted on 2025-01-07
US20210401852A1
Human necessities

Treatment and prevention of premature ejaculation (PE)

#994
US20210401853A1
Human necessities

METHODS OF TREATING NEURODEVELOPMENTAL DISORDERS

#995 ✅ Patent 11,969,432 granted on 2024-04-30
US20210401854A1
Human necessities

Pharmaceutical composition and use thereof

#996
US20210401855A1
Human necessities

PHARMACEUTICAL FORMULATION CONTAINING COMBINATION OF M3 ANTAGONIST-BETA-2 AGONIST AND INHALED CORTICOSTEROIDS

#997
US20210401856A1
Human necessities

Nasal Delivery of Low-Dose Aspirin for the Treatment of Neurodegenerative and Lysosomal Storage Diseases

#998 ✅ Patent 11,684,628 granted on 2023-06-27
US20210401857A1
Human necessities

Di-isopropyl-phosphinoyl-alkanes (DAPA) compounds as topical agents for the treatment of sensory discomfort

#999
US20210401858A1
Human necessities

PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTIONS

#1000
US20210401859A1
Human necessities

METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS WITH NON-COVALENT INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

#1001
US20210401860A1
Human necessities

Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine

#1002 ✅ Patent 11,883,422 granted on 2024-01-30
US20210401861A1
Human necessities

Glycan therapeutic compositions and related methods thereof

#1003
US20210401862A1
Human necessities

METHODS FOR MODULATING CORTICOSTERONE LEVELS IN PSYCHOLOGICALLY STRESSED INDIVIDUALS

#1004
US20210401863A1
Human necessities

TREATMENT AND PREVENTION OF NEISSERIA GONORRHOEAE INFECTION USING CMP-ACTIVATED NONULOSONATE ANALOG COMPOUNDS

#1005 ✅ Patent 11,439,654 granted on 2022-09-13
US20210401864A1
Human necessities

Topical analgesic

#1006 ✅ Patent 11,590,154 granted on 2023-02-28
US20210401865A1
Human necessities

Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

#1007 ✅ Patent 11,311,565 granted on 2022-04-26
US20210401866A1
Human necessities

Synergistic nutritional compositions for promoting axonal regeneration

#1008
US20210401867A1
Human necessities

PHOTOSENSITIZERS AND METHOD OF TREATING CANCER USING THE SAME

#1009 ✅ Patent 11,617,760 granted on 2023-04-04
US20210401868A1
Human necessities

Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules

#1010
US20210401869A1
Human necessities

Antisense Compounds Targeting Genes Associated with Cystic Fibrosis

#1011
US20210401870A1
Human necessities

USE OF SOY HULL POLYSACCHARIDE IN PREPARATION OF DRUGS FOR MODULATING INTESTINAL FLORA, REDUCING BLOOD GLUCOSE AND BLOOD LIPID, AND RESISTING INFLAMMATION, AND OF FOODS FOR SPECIAL MEDICAL PURPOSE

#1012
US20210401871A1
Human necessities

OLIGONUCLEOTIDES TO TREAT EYE DISEASE

#1013 ✅ Patent 11,642,367 granted on 2023-05-09
US20210401872A1
Human necessities

Hyperosmolar composition of hyaluronic acid

#1014 ✅ Patent 12,109,225 granted on 2024-10-08
US20210401873A1
Human necessities

Methods for potentiating cancer treatment using ionizing radiation

#1015 ✅ Patent 11,723,916 granted on 2023-08-15
US20210401874A1
Human necessities

Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids

#1016 ✅ Patent 11,458,159 granted on 2022-10-04
US20210401875A1
Human necessities

Oxygen carriers for the treatment of skin indispositions

#1017
US20210401876A1
Human necessities

PHARMACEUTICAL COMPOSITION OF CHLORINE FOR TREATMENT OF RESPIRATORY VIRAL INFECTION

#1018 ✅ Patent 11,517,586 granted on 2022-12-06
US20210401877A1
Human necessities

Instructions for composition and sensitivity

#1019
US20210401878A1
Human necessities

Stable Pharmaceutical Articles Containing Dilute Povidone Iodine Formulations

#1020
US20210401879A1
Human necessities

COMPOSITIONS FOR CONTROLLING ODOR AND ITCH AND METHODS OF AND DEVICES FOR ADMINISTERING SAME

#1021
US20210401880A1
Human necessities

Pharmaceutical Composition For Preventing Or Treating Obesity, Containing CYCLO(HIS-PRO) As Active Ingredient

#1022 ✅ Patent 12,109,232 granted on 2024-10-08
US20210401881A1
Human necessities

Radiation/chemotherapy sensitizer to be used for intratumoral local injection and for controlled release of hydrogen peroxide with hydrogel as carrier

#1023 ✅ Patent 11,963,978 granted on 2024-04-23
US20210401882A1
Human necessities

Method for preparing cell extract component or composition having cytocidal activity

#1024
US20210401883A1
Human necessities

METHODS FOR MANAGING ADVERSE EVENTS IN PATIENTS WITH INFLAMMATION

#1025
US20210401884A1
Human necessities

MICROSPHERE-BASED DELIVERY AND EX VIVO MANIPULATION OF DENDRITIC CELLS FOR AUTOIMMUNE THERAPIES

#1026
US20210401885A1
Human necessities

CANCER ANTIGEN SPECIFIC CYTOTOXIC T CELL

#1027 ✅ Patent 12,257,286 granted on 2025-03-25
US20210401886A1
Human necessities

Methods and materials for treating cancer

#1028
US20210401887A1
Human necessities

T CELLS FROM LYMPHATIC FLUID FOR DIAGNOSTIC AND THERAPEUTIC USE

#1029 ✅ Patent 12,221,468 granted on 2025-02-11
US20210401888A1
Human necessities

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

#1030 ✅ Patent 11,304,980 granted on 2022-04-19
US20210401889A1
Human necessities

Restimulation of cryopreserved tumor infiltrating lymphocytes

#1031
US20210401890A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR T LYMPHOCYTE FOR TREATING TUMORS, PREPARATION METHOD THEREFOR, AND USE THEREOF

#1032 ✅ Patent 11,464,803 granted on 2022-10-11
US20210401891A1
Human necessities

D-domain containing polypeptides and uses thereof

#1033 ✅ Patent 11,369,636 granted on 2022-06-28
US20210401892A1
Human necessities

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1034
US20210401893A1
Human necessities

T CELL EXPRESSING AN FC GAMMA RECEPTOR AND METHODS OF USE THEREOF

#1035
US20210401894A1
Human necessities

Native whey protein for treating and/or preventing intestinal infection

#1036
US20210401895A1
Human necessities

TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH LIVE BIOTHERAPEUTICS

#1037 ✅ Patent 11,872,251 granted on 2024-01-16
US20210401896A1
Human necessities

Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction

#1038
US20210401897A1
Human necessities

METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME

#1039
US20210401898A1
Human necessities

USE OF IMMORTALIZED PLACENTAL STEM CELLS IPSC/EXTRACELLULAR VESICLES TO ENHANCE THERAPEUTIC RECOVERY FROM TISSUE DAMAGE AND ISCHEMIA-REPERFUSION INJURY AND DELAYED ORGAN FUNCTION

#1040 ✅ Patent 11,944,651 granted on 2024-04-02
US20210401899A1
Human necessities

Antimicrobial and antiviral agent, antimicrobial and antiviral member, and method for producing antimicrobial and antiviral agent

#1041
US20210401900A1
Human necessities

ENTERIC COMPOSITION, FOOD OR BEVERAGE PRODUCT CONTAINING THE SAME, METHOD FOR CONTROLLING DISINTEGRATION TIME OF THE SAME, AND METHOD FOR MANUFACTURING THE SAME

#1042 ✅ Patent 11,786,563 granted on 2023-10-17
US20210401901A1
Human necessities

Spore-based probiotic composition for modulation of dermal and sub-dermal properties

#1043 ✅ Patent 11,801,271 granted on 2023-10-31
US20210401902A1
Human necessities

Stable bacterial extracts as pharmaceuticals

#1044 ✅ Patent 11,491,195 granted on 2022-11-08
US20210401903A1
Human necessities

Composition comprising CJLP475 strain and CJLP17 strain and use thereof

#1045
US20210401904A1
Human necessities

PREBIOTIC FORMULATIONS FOR PREVENTION OF SEPSIS AND NECROENTEROCOLITIS INDUCED NEURODEVELOPMENTAL DEFICIENCIES

#1046
US20210401905A1
Human necessities

COMBINATION OF LACTOBACILLI FOR THE RELIEF OF IRRITABLE BOWEL SYNDROME AND FOR THE RELIEF OF OTHER GASTROINTESTINAL DISORDERS

#1047 ✅ Patent 11,969,447 granted on 2024-04-30
US20210401906A1
Human necessities

Use of spray-dried powder derived from lactic acid bacterial strains and herbal extracts for promoting defecation

#1048 ✅ Patent 12,161,682 granted on 2024-12-10
US20210401907A1
Human necessities

Topical composition and method of improving skin diseases and dermatitis using the same

#1049 ✅ Patent 11,717,546 granted on 2023-08-08
US20210401908A1
Human necessities

Composition for promoting defecation and use therefor

#1050 ✅ Patent 11,406,675 granted on 2022-08-09
US20210401909A1
Human necessities

Therapeutic pharmaceutical compositions

#1051
US20210401910A1
Human necessities

EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING THE SAME

#1052 ✅ Patent 11,235,012 granted on 2022-02-01
US20210401911A1
Human necessities

Combination and use of red propolis and red algae

#1053
US20210401912A1
Human necessities

USE OF ANTRODIA CINNAMOMEA COMPOSITION FOR IMMUNE MODULATION

#1054 ✅ Patent 11,666,617 granted on 2023-06-06
US20210401913A1
Human necessities

Treatment of warts

#1055
US20210401914A1
Human necessities

ORAL COMPOSITION FOR ANIMAL AND PERIODONTAL DISEASE PREVENTIVE, INFECTION DISEASE PREVENTIVE, AND MOUTH ODOR PREVENTIVE USING THE ORAL COMPOSITION

#1056
US20210401915A1
Human necessities

COMPOSITIONS AND METHODS FOR THE MANAGEMENT OF MUCOSITIS IN MAMMALS

#1057
US20210401916A1
Human necessities

COMPOSITION FOR PREVENTION AND TREATMENT OF MUSCULAR DISEASES OR FOR IMPROVEMENT OF MUSCLE FUNCTION CONTAINING 3,5-DICAFFEOYLQUINIC ACID OR CHRYSANTHEMUM EXTRACT

#1058 ✅ Patent 11,903,989 granted on 2024-02-20
US20210401917A1
Human necessities

Botanical modulator of metabolic disorders

#1059
US20210401918A1
Human necessities

COMPOSITION COMPRISING COMBINATION OF RED CLOVER EXTRACT AND HOPS EXTRACT FOR IMPROVEMENT OF MENOPAUSAL DISORDER

#1060
US20210401919A1
Human necessities

Ophthalmic Compositions

#1061 ✅ Patent 11,564,965 granted on 2023-01-31
US20210401920A1
Human necessities

Compositions for the treatment of , acne and joint pain

#1062 ✅ Patent 11,865,156 granted on 2024-01-09
US20210401921A1
Human necessities

Treatment of tobacco addiction by a tobacco leaf extract

#1063
US20210401922A1
Human necessities

Novel Cannabinoid Carrier Compositions Having Enhance Pharmacokinetic Properties And Methods of Use Thereof

#1064 ✅ Patent 11,771,734 granted on 2023-10-03
US20210401923A1
Human necessities

Methods and compositions for the prevention or treatment of Barth syndrome

#1065 ✅ Patent 11,911,434 granted on 2024-02-27
US20210401924A1
Human necessities

Stable antibody-drug conjugate, preparation method therefor, and use thereof

#1066
US20210401925A1
Human necessities

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY

#1067
US20210401926A1
Human necessities

PHARMACEUTICAL FORMULATIONS OF PEPTIDE INHIBITORS

#1068
US20210401927A1
Human necessities

Peptides Having Immunomodulatory Properties

#1069 ✅ Patent 12,178,839 granted on 2024-12-31
US20210401928A1
Human necessities

Anti-obesity agent, pollakiuria improving agent, and autonomic nervous activity regulator

#1070
US20210401929A1
Human necessities

CELL PENETRATING SHORT PEPTIDE TAT-HUR-HNS-3 AND APPLICATION THEREOF IN INFLAMMATORY DISEASE

#1071 ✅ Patent 12,083,160 granted on 2024-09-10
US20210401930A1
Human necessities

Polypeptides binding to human complement C5

#1072
US20210401931A1
Human necessities

METHODS AND MATERIALS FOR TREATING CANCER

#1073 ✅ Patent 11,925,673 granted on 2024-03-12
US20210401932A1
Human necessities

Treatment of age-related macular degeneration

#1074
US20210401933A1
Human necessities

IMMUNE CHECKPOINT INHIBITOR COMBINATIONS

#1075
US20210401934A1
Human necessities

PROTEIN FUNCTIONALIZED HYALURONIC ACID COATED CHITOSAN NANOPARTICLE AND METHOD OF PREPARATION

#1076
US20210401935A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CARTILAGE DISEASES

#1077 ✅ Patent 12,036,265 granted on 2024-07-16
US20210401936A1
Human necessities

Compositions and methods relating to bone repair and regeneration

#1078
US20210401937A1
Human necessities

COMPOSITION AND METHOD FOR ARTHRITIS

#1079
US20210401938A1
Human necessities

METHODS FOR TREATING CARDIAC INJURY

#1080
US20210401939A1
Human necessities

METHODS OF TREATING AN AUTOIMMUNE DISEASE

#1081 ✅ Patent 12,083,163 granted on 2024-09-10
US20210401940A1
Human necessities

Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases

#1082
US20210401941A1
Human necessities

MULTILAYER DRUG DELIVERY COATING FOR CONTACT LENS

#1083 ✅ Patent 12,109,251 granted on 2024-10-08
US20210401942A1
Human necessities

Satiation peptide administration

#1084 ✅ Patent 12,186,373 granted on 2025-01-07
US20210401943A1
Human necessities

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid

#1085
US20210401944A1
Human necessities

COMPOSITION AND METHODS FOR REGULATING CHONDROCYTE PROLIFERATION AND INCREASING OF CARTILAGE MATRIX PRODUCTION

#1086 ✅ Patent 11,964,003 granted on 2024-04-23
US20210401945A1
Human necessities

Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

#1087
US20210401946A1
Human necessities

CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN

#1088
US20210401947A1
Human necessities

CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN

#1089
US20210401948A1
Human necessities

POLYMER-FACTOR VIII MOIETY CONJUGATES

#1090 ✅ Patent 12,295,991 granted on 2025-05-13
US20210401949A1
Human necessities

Hemoglobin derivative co-conjugated with fatty acid-linked PEG and alkoxy PEG as a blood substitute

#1091
US20210401950A1
Human necessities

COMPOSITIONS FOR TREATING PATHOLOGICAL CALCIFICATION CONDITIONS, AND METHODS USING SAME

#1092 ✅ Patent 11,712,463 granted on 2023-08-01
US20210401951A1
Human necessities

MRNA therapy for pompe disease

#1093
US20210401952A1
Human necessities

Method of treating AML subtypes using arginine-depleting agents

#1094
US20210401953A1
Human necessities

ASPARAGINASE THERAPEUTIC METHODS

#1095
US20210401954A1
Human necessities

COMPOSITIONS FOR THE INHIBITION OF GIARDIA LAMBLIA

#1096
US20210401955A1
Human necessities

CD4 T cells provide antibody access to immunoprivileged tissue

#1097 ✅ Patent 12,285,474 granted on 2025-04-29
US20210401956A1
Human necessities

Vsg-based vaccination and antibody generation platform for the treatment of diseases

#1098
US20210401957A1
Human necessities

ROBO1 CAR-NK CELL CARRYING SUICIDE GENE, PREPARATION METHOD AND APPLICATION THEREOF

#1099 ✅ Patent 12,161,706 granted on 2024-12-10
US20210401958A1
Human necessities

Cancer vaccines targeting BORIS and uses thereof

#1100 ✅ Patent 11,986,517 granted on 2024-05-21
US20210401959A1
Human necessities

Cancer vaccines targeting mesothelin and uses thereof

#1101
US20210401960A1
Human necessities

MULTIVALENT GLYCOCONJUGATES IMMUNOGENIC COMPOSITIONS

#1102
US20210401961A1
Human necessities

METHODS OF TUMOR VACCINATION

#1103 ✅ Patent 11,564,981 granted on 2023-01-31
US20210401962A1
Human necessities

Vaccine for prevention of necrotic enteritis in poultry

#1104 ✅ Patent 11,911,452 granted on 2024-02-27
US20210401963A1
Human necessities

Multivalent pneumococcal polysaccharide-protein conjugate composition

#1105 ✅ Patent 11,707,514 granted on 2023-07-25
US20210401964A1
Human necessities

Neisseria meningitidis vaccine

#1106 ✅ Patent 12,296,001 granted on 2025-05-13
US20210401965A1
Human necessities

DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV)

#1107 ✅ Patent 12,168,050 granted on 2024-12-17
US20210401966A1
Human necessities

Compositions comprising a norovirus nucleic acid and methods of use thereof

#1108 ✅ Patent 11,793,870 granted on 2023-10-24
US20210401967A1
Human necessities

Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

#1109
US20210401968A1
Human necessities

Localized activation of virus replicatio boosts herpesvirus-vectored vaccines

#1110 ✅ Patent 12,370,252 granted on 2025-07-29
US20210401969A1
Human necessities

RSV VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF

#1111
US20210401970A1
Human necessities

CANINE DISTEMPER VACCINES AND METHODS OF TREATMENT USING THE SAME

#1112 ✅ Patent 11,865,084 granted on 2024-01-09
US20210401971A1
Human necessities

MERS coronavirus vaccine

#1113 ✅ Patent 11,801,298 granted on 2023-10-31
US20210401972A1
Human necessities

MERS-CoV vaccine

#1114 ✅ Patent 11,730,807 granted on 2023-08-22
US20210401973A1
Human necessities

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

#1115
US20210401974A1
Human necessities

Pharmaceutical compositions, vaccines and their uses in the prevention or treatment of a persistent infection or of cancer

#1116 ✅ Patent 11,806,318 granted on 2023-11-07
US20210401975A1
Human necessities

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

#1117
US20210401976A1
Human necessities

IMMUNOGENIC PEPTIDES WITH IMPROVED OXIDOREDUCTASE MOTIFS

#1118 ✅ Patent 11,559,578 granted on 2023-01-24
US20210401977A1 ⚡
Human necessities

Biodegradable cationic polycarbonates as adjuvants for vaccines

#1119
US20210401978A1
Human necessities

Checkpoint Inhibitor and Vaccine Combinations and Use of Same for Immunotherapy

#1120 ✅ Patent 12,274,746 granted on 2025-04-15
US20210401979A1
Human necessities

Dosing parameters for CD47 targeting therapies to hematologic malignancies

#1121 ✅ Patent 11,419,935 granted on 2022-08-23
US20210401980A1
Human necessities

Immunotherapy method comprising administering a combination of immune effector cells and non-target hematopoietic cells

#1122 ✅ Patent 11,571,477 granted on 2023-02-07
US20210401981A1
Human necessities

Anti-VLA-4 antibodies

#1123
US20210401982A1
Human necessities

STABLE FORMULATIONS OF THERAPEUTIC ANTIBODY

#1124
US20210401983A1
Human necessities

ARTHROGENIC ALPHAVIRUS VACCINE

#1125
US20210401984A1
Human necessities

IMMUNOPROTECTIVE PRIMARY MESENCHYMAL STEM CELLS AND METHODS

#1126
US20210401985A1
Human necessities

COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY

#1127
US20210401986A1
Human necessities

METHODS FOR MANUFACTURING PHTHALOCYANINE DYE CONJUGATES AND STABLE CONJUGATES

#1128
US20210401987A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND FIBROTIC PULMONARY DISORDERS

#1129
US20210401988A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

#1130
US20210401989A1
Human necessities

SEMI-SOLID, OIL-BASED PHARMACEUTICAL COMPOSITIONS CONTAINING PIRFENIDONE FOR APPLICATION IN TISSUE REPAIR

#1131 ✅ Patent 11,701,425 granted on 2023-07-18
US20210401990A1
Human necessities

Valerian composition and related methods

#1132 ✅ Patent 11,491,225 granted on 2022-11-08
US20210401991A1
Human necessities

Transdermal carrier

#1133
US20210401992A1
Human necessities

METABOLICALLY STABLE PRODRUGS

#1134
US20210401993A1
Human necessities

TREATING INFLAMMATION USING LLP2A-BISPHOSPHONATE CONJUGATES AND MESENCHYMAL STEM CELLS

#1135 ✅ Patent 11,896,674 granted on 2024-02-13
US20210401994A1
Human necessities

SiRNA conjugate, preparation method therefor and use thereof

#1136
US20210401995A1
Human necessities

TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS

#1137
US20210401996A1
Human necessities

TETRACYCLINE COMPLEXES WITH SUSTAINED ACTIVITY

#1138 ✅ Patent 11,844,841 granted on 2023-12-19
US20210401997A1
Human necessities

Dosing regimens and related compositions and methods

#1139
US20210401998A1
Human necessities

METHODS OF TREATING CYP2D6 ALTERNATIVE METABOLIZERS

#1140
US20210401999A1
Human necessities

METHODS OF TREATING DISEASES RELATED TO NET FORMATION WITH PARENTERAL ADMINISTRATION OF POLYSIALYLATED DNASE I

#1141
US20210402000A1
Human necessities

HIGH-POLYMER-DENSITY BIOCONJUGATE COMPOSITIONS AND RELATED METHODS

#1142
US20210402001A1
Human necessities

Zinc Porters, and their Monoclonal Antibody Conjugates, for the Prevention and Treatment of COVID-19 (SARS-CoV-2), Other Infections, and Cancers

#1143
US20210402002A1
Human necessities

CONJUGATE

#1144
US20210402003A1
Human necessities

METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-VEGF ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE

#1145
US20210402004A1
Human necessities

NANOPARTICLE STRUCTURE AND METHOD OF FORMING THE SAME

#1146
US20210402005A1
Human necessities

METHODS AND COMPOSITIONS FOR TARGETING T-CELL CANCERS

#1147
US20210402006A1
Human necessities

NANOPARTICLES AND USES THEREOF

#1148
US20210402007A1
Human necessities

POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF

#1149 ✅ Patent 12,121,593 granted on 2024-10-22
US20210402008A1
Human necessities

Therapy

#1150
US20210402009A1
Human necessities

CARBON NANOTUBE COMPOSITE VECTOR HAVING SYNERGISTIC EFFECT OF PHOTOTHERMAL THERAPY AND GENE THERAPY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#1151 ✅ Patent 11,951,182 granted on 2024-04-09
US20210402010A1
Human necessities

Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor

#1152
US20210402011A1
Human necessities

A COMPOUND FOR THE DETECTION OF HNO IN BIOLOGICAL SYSTEMS

#1153
US20210402012A1
Human necessities

PARTICLE COMPRISING LANTHANIDE HYDROXIDE

#1154
US20210402013A1
Human necessities

FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING

#1155
US20210402014A1
Human necessities

COMPLEX POLYSACCHARIDE-BOUND RADIOISOTOPE CHELATES AND METHODS OF TREATING MALIGNANCIES THEREWITH

#1156
US20210402015A1
Human necessities

HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS

#1157
US20210402016A1
Human necessities

RADIOLABELED BOMBESIN-DERIVED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS

#1158
US20210402017A1
Human necessities

METHOD FOR INACTIVATING A VIRUS ON A SURFACE

#1159 ✅ Patent 11,547,768 granted on 2023-01-10
US20210402018A1
Human necessities

Unified airflow system for ultraviolet disinfection devices

#1160
US20210402019A1
Human necessities

UVC LIGHTING SYSTEM

#1161
US20210402020A1
Human necessities

PORTABLE STERILIZATON CONTAINER

#1162
US20210402021A1
Human necessities

Ultraviolet light equipment rack

#1163
US20210402022A1
Human necessities

Ultraviolet light pod

#1164 ✅ Patent 12,318,494 granted on 2025-06-03
US20210402023A1
Human necessities

Methods and systems for UV-based aircraft decontamination

#1165
US20210402024A1
Human necessities

UVC-LED light technology integrated for use in cell phone and tablets.

#1166
US20210402025A1
Human necessities

DEVICE FOR DISINFECTING CABLES AND WIRES AND A METHOD FOR DISINFECTING CABLES AND WIRES

#1167 ✅ Patent 11,426,477 granted on 2022-08-30
US20210402026A1
Human necessities

Systems and methods for UV decontamination of respirators

#1168 ✅ Patent 11,559,594 granted on 2023-01-24
US20210402027A1
Human necessities

Hybrid far UV-C and visible lamp

#1169
US20210402028A1 ⚡
Human necessities

METHOD AND DEVICE WITH OBJECT INACTIVATION

#1170 ✅ Patent 12,186,444 granted on 2025-01-07
US20210402029A1
Human necessities

Apparatus and method for treating shoes

#1171
US20210402030A1
Human necessities

SANITIZING DEVICE FOR VENDING MACHINES

#1172
US20210402031A1
Human necessities

PORTABLE SANITIZING CONTAINER

#1173 ✅ Patent 12,246,107 granted on 2025-03-11
US20210402032A1
Human necessities

Multi-layer bag with loss of integrity means of detection

#1174
US20210402033A1
Human necessities

Sterilization Indicator Reading Apparatus with a Color Sensor

#1175
US20210402034A1
Human necessities

FLUORORUBBER WAX-MELTING TRAY AND CLEANING METHOD THEREOF

#1176 ✅ Patent 11,771,793 granted on 2023-10-03
US20210402035A1
Human necessities

Malodor reduction in air care applications

#1177
US20210402036A1
Human necessities

DEVICES AND METHODS FOR SELECTIVELY PROVIDING AN ODOR-RICH ENVIRONMENT

#1178
US20210402037A1
Human necessities

ADAPTIVE FRAGRANCE DISPENSER

#1179 ✅ Patent 12,186,460 granted on 2025-01-07
US20210402038A1
Human necessities

Air decontamination apparatus for HVAC systems

#1180 ✅ Patent 11,717,590 granted on 2023-08-08
US20210402039A1
Human necessities

Compression-based portable air treatment systems and methods

#1181 ✅ Patent 11,383,000 granted on 2022-07-12
US20210402040A1
Human necessities

Aerosol sterilization surgical lamp using UV light and visible light

#1182 ✅ Patent 11,865,235 granted on 2024-01-09
US20210402041A1
Human necessities

Vehicle cabin disinfection systems and methods

#1183
US20210402042A1
Human necessities

AIR FILTRATION SYSTEM

#1184 ✅ Patent 11,813,379 granted on 2023-11-14
US20210402043A1
Human necessities

Sterilization and disinfection lamp

#1185 ✅ Patent 11,484,620 granted on 2022-11-01
US20210402044A1
Human necessities

Airborne pathogen extraction system

#1186 ✅ Patent 11,806,558 granted on 2023-11-07
US20210402045A1
Human necessities

Body-worn air-treatment devices and methods of deactivating pathogens

#1187
US20210402046A1
Human necessities

DISINFECTING SANITARY SYSTEM FOR INACTIVATING AIRBORNE PATHOGENS WITHIN A SANITARY DEVICE

#1188 ✅ Patent 11,911,524 granted on 2024-02-27
US20210402047A1
Human necessities

Biomedical foams

#1189
US20210402048A1
Human necessities

THIN-FILM VEHICLES THAT STABILIZE HIGHLY REACTIVE ACTIVE INGREDIENTS

#1190 ✅ Patent 11,717,592 granted on 2023-08-08
US20210402049A1
Human necessities

Bioresorbable dressing with structural support

#1191
US20210402050A1
Human necessities

COMPOSITE MEDICAL TEXTILE WITH NON-RESORBABLE FIBERS AND BIORESORBABLE HYALURONAN-BASED FIBERS

#1192 ✅ Patent 11,986,571 granted on 2024-05-21
US20210402051A1
Human necessities

Radiopaque polymeric liquid embolic system

#1193
US20210402052A1
Human necessities

Medical Implants And Methods Of Manufacture

#1194
US20210402053A1
Human necessities

MINERALIZATION OF CELL-LADEN MATRICES

#1195 ✅ Patent 12,102,730 granted on 2024-10-01
US20210402054A1
Human necessities

Graphene-based nanofibers for skeletal muscle tissue regeneration

#1196 ✅ Patent 11,793,907 granted on 2023-10-24
US20210402055A1
Human necessities

Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same

#1197
US20210402056A1
Human necessities

BONE GRAFT SUBSTITUTE

#1198
US20210402057A1
Human necessities

PROCESS FOR OBTAINING DECELLULARIZED EXTRACELLULAR MATRIX, DECELLULARIZED EXTRACELLULAR MATRIX, USE THEREOF AND KIT

#1199 ✅ Patent 12,201,747 granted on 2025-01-21
US20210402058A1
Human necessities

Compositions and methods for treatment of bone defects

#1200 ✅ Patent 11,878,090 granted on 2024-01-23
US20210402059A1
Human necessities

Solid substrates for promoting cell and tissue growth